REGENERON PHARMACEUTICALS

Ticker: REGN CUSIP: 75886F107 Class: COM

E&G Advisors, LP's Holding History (CIK: 0001598550)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 291 Value ($000) $207 Avg Close $834.60 Range $689.18 - $1055.74
Q3 2024
Shares 301 Value ($000) $316 Avg Close $1106.73 Range $1002.85 - $1204.52
Q2 2024
Shares 301 Value ($000) $316 Avg Close $964.05 Range $870.40 - $1075.21
Q1 2024
Shares 301 Value ($000) $290 Avg Close $945.64 Range $866.58 - $992.82
Q4 2023
Shares 301 Value ($000) $264 Avg Close $818.96 Range $764.95 - $894.90
Q3 2023
Shares 305 Value ($000) $251 Avg Close $781.58 Range $684.72 - $842.83
Q2 2023
Shares 305 Value ($000) $219 Avg Close $766.75 Range $681.03 - $832.93
Q1 2023
Shares 305 Value ($000) $251 Avg Close $750.05 Range $664.32 - $830.39
Q4 2022
Shares 310 Value ($000) $224 Avg Close $733.79 Range $690.81 - $774.70
Q3 2022
Shares 310 Value ($000) $214 Avg Close $625.92 Range $560.71 - $750.51
Q1 2022
Shares 310 Value ($000) $217 Avg Close $629.16 Range $589.59 - $706.29